Drug Shortage Report for HEPARIN SODIUM INJECTION USP

Last updated on 2019-10-29 History
Report ID 93960
Drug Identification Number 02382326
Brand name HEPARIN SODIUM INJECTION USP
Common or Proper name HEPARIN SODIUM INJECTION USP
Company Name PFIZER CANADA ULC
Active Ingredient(s) HEPARIN SODIUM
Strength(s) 10000UNIT
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS
Packaging size 25 x 1mL GVL
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-11
Estimated end date 2019-11-22
Actual end date
Shortage status Actual shortage
Updated date 2019-10-29
Company comments Only one lot with an expiry date of 1/31/2020 remains available
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-10-29 French Compare
v6 2019-10-29 English Compare
v5 2019-10-12 English Compare
v4 2019-10-11 French Compare
v3 2019-10-11 English Compare
v2 2019-09-16 French Compare
v1 2019-09-16 English Compare